ARWR Historical Earnings image   This ARWR historical earnings page last updated 11/23/2022
ARWR Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 20228/4/20220.03B
Q2 20225/10/20220.15B
Q1 20222/2/20220.03B
Q4 202111/22/20210.04B
Q3 20218/5/20210.05B
Q2 20215/4/20210.03B
Q1 20212/4/20210.02B
Q4 202011/23/20200.01B
Q3 20208/5/20200.03B
Q2 20205/7/20200.02B
Q1 20202/5/20200.03B
Q4 201911/25/20190.04B
Q3 20198/5/20190.04B
Q2 20195/8/20190.05B
Q1 20192/7/201934.66M
Q4 201812/11/201811.26M
Q3 20188/7/2018727375
Q2 20185/8/2018650125
Q1 20182/9/20183.51M
Q4 201712/12/20178.71M
Q3 20178/3/20179.34M
Q2 20175/3/20178.99M
Q1 20172/6/20174.37M
Q4 201612/14/201631250
Q3 20168/9/201639583
Q2 20165/10/201643750
Q1 20162/9/201643750
Q4 201512/14/201543750
Q3 20158/4/2015123750
Q2 20155/11/201543750
Q1 20152/9/2015170750
Q4 201411/25/201440000
Q3 20148/12/201440000
Q2 20145/6/201443750
Q1 20144/4/20144.60M
FY 201312/18/2013290266
Q3 20138/7/201343750
Q2 20135/9/201343750
Q1 20132/4/20130.05M
Q4 201212/20/20120.04M
ARWR Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 20228/4/2022-0.680
Q2 20225/10/20220.410
Q1 20222/2/2022-0.600
Q4 202111/22/2021-0.610
Q3 20218/5/2021-0.290
Q2 20215/4/2021-0.260
Q1 20212/4/2021-0.200
Q4 202011/23/2020-0.480
Q3 20208/5/2020-0.130
Q2 20205/7/2020-0.200
Q1 20202/5/2020-0.030
Q4 201911/25/20190.110
Q3 20198/5/20190.210
Q2 20195/8/20190.240
Q1 20192/7/20190.13
Q4 201812/11/2018-0.12
Q3 20188/7/2018-0.18
Q2 20185/8/2018-0.18
Q1 20182/9/2018-0.18
Q4 201712/12/2017-0.15
Q3 20178/3/2017-0.07
Q2 20175/3/2017-0.08
Q1 20172/6/2017-0.17
Q4 201612/14/2016-0.34
Q3 20168/9/2016-0.32
Q2 20165/10/2016-0.35
Q1 20162/9/2016-0.32
Q4 201512/14/2015-0.41
Q3 20158/4/2015-0.27
Q2 20155/11/2015-0.51
Q1 20152/9/2015-0.41
Q4 201411/25/2014-0.42
Q3 20148/12/2014-0.22
Q2 20145/6/20140.31
Q1 20144/4/20140.28
FY 201312/18/2013-1.3
Q3 20138/7/2013-0.23
Q2 20135/9/2013-0.41
Q1 20132/4/2013-0.28
Q4 201212/20/2012-0.43
Quotes delayed 20 minutes

Email EnvelopeFree ARWR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Arrowhead Pharmaceuticals (ARWR) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ASMB Historical Earnings
ASRT Historical Earnings
ATEC Historical Earnings
ATHA Historical Earnings
ATHX Historical Earnings
ATIP Historical Earnings
ATNF Historical Earnings
ATNX Historical Earnings
ATOS Historical Earnings
ATRA Historical Earnings
What was the record high ARWR historical earnings result?
In terms of earnings or revenue, what is the best ARWR historical earnings result that Arrowhead Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest ARWR historical earnings result was set in Q2 2022, when Arrowhead Pharmaceuticals posted results of 0.410/share. The most successful revenue quarter within our data set was Q2 2022 when Arrowhead Pharmaceuticals reported revenue of 0.15B.

What was the lowest Arrowhead Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest ARWR has reported, and when?

✔️Accepted answer: Within our data set, the lowest ARWR historical earnings result was set in FY 2013, when Arrowhead Pharmaceuticals posted results of -1.3/share. The smallest revenue quarter within our data set was Q4 2016 when Arrowhead Pharmaceuticals reported revenue of 31250.

On this page we presented the ARWR historical earnings date information for Arrowhead Pharmaceuticals. Reviewing that ARWR Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2022, when ARWR posted gaap of 0.410/share. Meanwhile the lowest ARWR historical earnings result was in FY 2013, when ARWR posted gaap of -1.3/share. Moving to Arrowhead Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2022 when ARWR reported 0.15B in revenue, while the smallest revenue quarter was Q4 2016 when ARWR reported 31250 in revenue.

For self directed investors doing their due diligence on ARWR or any other given stock, their research can benefit from looking into all of the Arrowhead Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Arrowhead Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for ARWR. Thanks for visiting, and the next time you need to research ARWR historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Institutional Holders of UG, Nasdaq OMX Group DMA, PDLB Historical Stock Prices.

 

ARWR Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.